ReviewCureus2026
A Narrative Review of Urodynamics in Men With Lower Urinary Tract Symptoms: Diagnostic Test, Treatment-Decision Tool, or Prognostic Marker?
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lower urinary tract symptoms (LUTS) in men are common, multifactorial, and frequently difficult to attribute to a single underlying mechanism. Although invasive urodynamic studies (UDS), particularly pressure-flow studies, have long been considered the reference standard for physiological characterization of bladder outlet obstruction (BOO), detrusor underactivity (DU), and mixed dysfunction, their routine use has come under increasing scrutiny in recent years. This narrative review evaluates the contemporary role of UDS in male LUTS as a diagnostic tool, treatment-decision aid, and prognostic marker. It also examines non-invasive alternatives, current controversies, and future directions. Current practice increasingly supports moving away from routine preoperative UDS in men with uncomplicated LUTS toward a more selective, indication-driven approach. UDS continues to offer important value in situations with greater diagnostic uncertainty, including young men with refractory symptoms, suspected DU, persistent symptoms after previous intervention, and neurogenic lower urinary tract dysfunction, where accurate assessment of storage pressures, compliance, and sphincter coordination may be important for upper urinary tract protection. Pressure-flow studies remain uniquely capable of differentiating BOO from impaired detrusor contractility and identifying mixed dysfunction when non-invasive tests are inconclusive. Non-invasive tools such as uroflowmetry, post-void residual measurement, ultrasound-derived parameters, and clinical prediction models may serve as useful triage instruments within a stepwise diagnostic pathway, but they have not yet replaced invasive UDS in complex or high-risk patients. Technical quality, standardization, and interobserver variability continue to represent important limitations of urodynamic testing. Contemporary practice, therefore, favors a selective approach to UDS in male LUTS, with its greatest clinical utility lying in the resolution of meaningful diagnostic uncertainty and support of individualized, phenotype-driven management rather than broad routine application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.